Type 2 Diabetes

ORLANDO — Exposure to bisphenol A may lower insulin sensitivity for healthy adults and may lead to higher risk for type 2 diabetes, according to a speaker at the American Diabetes Association Scientific Sessions.

Exposure to workplace sexual harassment was associated with elevated risk for developing CVD and type 2 diabetes, according to a study published in European Journal of Preventive Cardiology.

ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today Co-editor, talks with Camille Powe, MD, about benefits of use of continuous glucose monitoring during pregnancy.

Continuous glucose monitors have the potential to alleviate burdens, improve neonatal outcomes and predict disease progression for pregnant women with type 1, type 2 or gestational diabetes, according to two diabetes experts.

ORLANDO — Nearly one-quarter of adults with difficult-to-control type 2 diabetes also have hypercortisolism, and treating hypercortisolism may also benefit glycemic control in those with both conditions, according to speakers.

Teva Pharmaceuticals announced it has launched the first generic version of a GLP-1 receptor agonist in the United States, liraglutide 1.8 mg.

ORLANDO — In this video exclusive, Osagie Ebekozien, MD, MPH, CPHQ, chief medical officer at T1D Exchange, describes how the organization is moving research into practice.

“I’ve always wanted to be a doctor,” Samuel Dagogo-Jack, MD, DSc, this year’s recipient of the American Diabetes Association’s Outstanding Achievement in Clinical Diabetes Research Award, told Healio.

ORLANDO — A tubeless automated insulin delivery system improved multiple glycemic outcomes among a large group of adults with type 2 diabetes, according to data presented at the American Diabetes Association Scientific Sessions.

Fidelma Dunne, MD, PhD, FRCP, FRCPI, describes herself as a wife, mother, grandmother, sister and daughter who draws satisfaction from her family and from her career in endocrinology.